[1] Targher G, Byrne CD. Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type2 Diabetes and Its Complications [J]. J Clin Endocrinol Metab, 2013, 98(2):483-495. [2] Sun K, Lu J, Jiang Y,et al. Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders [J]. Clin Endocrinol (Oxf), 2014,80:348-355. [3] 肖明,刘道喜,郭俊勇.福辛普利单用与虫草菌粉联用治疗2型糖 尿病肾病早期患者疗效分析[J].中国现代医生,2013,51(2):60-61. [4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪 性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18: 163-166. [5] 于帅,王斌,杜娜,等.非酒精性脂肪肝患者并发2型糖尿病的风险 分析[J].山东医药,2015,1(3):50-52. [6] 郭雯,李杰,陈晓倩,等.2型糖尿病患者血钾水平与胰岛素抵抗及 胰岛功能的关系[J].中国糖尿病杂志,2017,25(1):35-39. [7] 郭雯,欣冰,仲彬,等.新诊断2型糖尿病患者血钾水平与非酒精性 脂肪性肝病的相关性研究[J].中国糖尿病杂志,2018,26(10): 817-820. [8] Honda F, Hiramatsu A, Hyogo H,et al. Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitor-ing [J]. PLoS One, 2018,13(4):e0195028.